Debra J. Bruzek - Concepedia

Concepedia

Author

Debra J. Bruzek

Johns Hopkins University

Also Known As

D Bruzek, D J Bruzek, D. J. Bruzek, D.J. Bruzek, DEBRA J. BRUZEK, Debra Bruzek, Debra J Bruzek, Debra J. Bruzek

39

Publications

1.8K

Citations

17

H-Index

40

Concepts

All Affiliations

Johns Hopkins University Bayer (United States)Johns Hopkins Hospital Johns Hopkins Medicine Memorial Sloan Kettering Cancer Center

DJ

About

Debra J. Bruzek is an author at Johns Hopkins University specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	1K
2	Health Sciences	2	2	35
3	Public Health	1	1	24
4	Allergy	1	1	13
5	Emergency Medicine	1	1	24

Debra J. Bruzek

×

23

Publications

1.8K

Citations

17

H-Index

	Year	Citations
Prostate Specific Antigen in the Preoperative and Postoperative Evaluation of Localized Prostatic Cancer Treated with Radical Prostatectomy Joseph E. Oesterling, Daniel W. Chan, Jonathan I. Epstein, The Journal of Urology UrologySurgical OncologyPerineural InvasionGenitourinary CancerPostoperative Evaluation	1988	585
INFLUENCE OF RADICAL PROSTATECTOMY ON SERUM HORMONE LEVELS Leslie R. Miller, Alan W. Partin, Daniel W. Chan, The Journal of Urology	1998	174
Prostate-specific antigen as a marker for prostatic cancer: a monoclonal and a polyclonal immunoassay compared. Daniel W. Chan, Debra J. Bruzek, Joseph E. Oesterling, Clinical Chemistry Reference IntervalsUrologyProstatic CancerGenitourinary CancerEndocrine-related Cancer	1987	173
COMPLEXED PROSTATE SPECIFIC ANTIGEN PROVIDES SIGNIFICANT ENHANCEMENT OF SPECIFICITY COMPARED WITH TOTAL PROSTATE SPECIFIC ANTIGEN FOR DETECTING PROSTATE CANCER Michael K. Brawer, Carol D Cheli, IRENE E. NEAMAN, The Journal of Urology	2000	149
Dissociation between androgen responsiveness for malignant growth vs. expression of prostate specific differentiation markers PSA, hK2, and PSMA in human prostate cancer models Samuel R. Denmeade, Lori J. Sokoll, Susan L. Dalrymple, The Prostate	2003	138
Identifying markers for pancreatic cancer by gene expression analysis. Wei Zhou, Lori J. Sokoll, Debra J. Bruzek, PubMed Pancreatic CancerMedicineImmunologyTissue InhibitorPathology	1998	115
ASSOCIATION BETWEEN SERUM ADIPONECTIN, AND PATHOLOGICAL STAGE AND GRADE IN MEN UNDERGOING RADICAL PROSTATECTOMY Stephen J. Freedland, Lori J. Sokoll, Elizabeth A. Platz, The Journal of Urology	2005	63
Molecular forms of prostate-specific antigen and human kallikrein 2 (hK2) in urine are not clinically useful for early detection and staging of prostate cancer Jürgen Pannek, Harry G. Rittenhouse, Cindy L. Evans, Urology Human Kallikrein 2UrologyGenitourinary CancerCancer DetectionMedicine	1997	41
Evaluation of a monoclonal immunoradiometric assay for prostate-specific antigen. Robert C. Rock, D. W. Chan, Debra J. Bruzek, Clinical Chemistry	1987	38
Short-term stability of the molecular forms of prostate-specific antigen and effect on percent complexed prostate-specific antigen and percent free prostate-specific antigen Lori J. Sokoll, Debra J. Bruzek, Renu Dua, Urology UrologyMolecular FormsShort-term StabilityBenign Prostatic HyperplasiaProstatic Disease	2002	33

Page 1